Categories: PR Newswire

Technological Advances in Biobetter and Biosimilar Platforms

NEW YORK, Oct. 7, 2019 /PRNewswire/ —

Therapeutically more effective drugs for the treatment of chronic diseases represents a crucial need.Biosimilars and biobetters offer the possibility to lower the cost of treating a variety of chronic diseases.

Read the full report: https://www.reportlinker.com/p05821890/?utm_source=PRN

In particular, biosimilars are the less expensive option; however, biobetters have demonstrated to be more effective, even over longer periods of time as compared to biosimilars.As the major factor propelling the market, both government and private sectors are progressively encouraging the usage of biosimilars and biobetters over conventional small molecules products.

In particular, Asian countries count with skilled labor availability, lower manufacturing costs, and less strict regulatory instruments, so that the Asian market for biosimilars and biobetters is expected to experiment a significant growth in the coming five years. The estimated expiration dates for patent, orphan and original approvals.

Among them, patents constitute the main factor determining the moment in which biosimilars can enter the market. The principal trends that are expected to favor the market over the next five years are leading manufacturers progressively focused on strategic collaborations, and a large number of market participants gradually outsourcing the production of biosimilar and biobetter products.Manufacturers claim for flexible, modular solutions to gain versatility, and thereby become more efficient in terms of yields and costs. Principal trends involve multiple production volumes production on different scales to easily meet the demand by manufacturing multiple products in the same facility, and hence obtain higher profits.

Read the full report: https://www.reportlinker.com/p05821890/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

http://www.reportlinker.com

IR Press

Share
Published by
IR Press

Recent Posts

OCC Announces Enforcement Actions for November 2024

WASHINGTON—The Office of the Comptroller of the Currency (OCC) today released enforcement actions taken against…

22 hours ago

Remarks by Secretary of the Treasury Janet L. Yellen on the 30th Anniversary of the Community Development Financial Institution Fund

As Prepared for Delivery Good afternoon. It’s an honor to welcome President Clinton to Treasury today…

2 days ago

Treasury Sanctions Gazprombank and Takes Additional Steps to Curtail Russia’s Use of the International Financial System

Treasury imposes sanctions on dozens of Russian banks, securities registrars, and finance officials; OFAC issues…

2 days ago

Acting Comptroller Testifies on State of the Federal Banking System

WASHINGTON—Acting Comptroller Michael J. Hsu today testified on the state of the federal banking system…

2 days ago

Remarks by Assistant Secretary for International Finance Brent Neiman on the U.S. Cross-Border Payments Agenda

As Prepared for Delivery Thank you very much for the opportunity to be here today, and…

4 days ago